go to top
A woman is briefed before taking a COVID-19 test in Groblersdal, South Africa A woman is briefed before taking a COVID-19 test in Groblersdal, South Africa, Feb. 11, 2021 (AP photo by Jerome Delay).

Can AstraZeneca Still Cure Africa’s Vaccine Woes?

Friday, Feb. 12, 2021

Editor’s Note: Every Friday, Andrew Green curates the top news and analysis from and about the African continent. Subscribers can adjust their newsletter settings to receive Africa Watch by email every week.

COVID-19 vaccination campaigns across Africa suffered a potentially serious blow after new research showed that a vaccine developed by Oxford University and AstraZeneca offered only minimal protection against mild and moderate infections caused by the more contagious coronavirus variant that was first detected in South Africa. The new strain has fueled a second wave of infections in the country and has been detected in at least 30 other nations, including six in Africa. ...

To read more,

enter your email address then choose one of the three options below.

Subscribe to World Politics Review and you'll receive instant access to 10,000+ articles in the World Politics Review Library, along with new comprehensive analysis every weekday . . . written by leading topic experts.